Alexa FluorRTM 594 anti-human CD4 [RPA-T4] and 4 more items

The University of Virginia has awarded contract A207_PO-0462010 to BioLegend Inc., a prime contractor specializing in life sciences research reagents. The contract was executed on July 25, 2026, with a cumulative value of $1,061.00. The contract encompasses the procurement of five fluorescently-labeled monoclonal antibodies for research applications, all of which are to be delivered to Mary Grachus Harp at the University of Virginia in Virginia.

The line items include: Alexa Fluor 594 anti-human CD4 [RPA-T4] at $185.50; Brilliant Violet 510 anti-human interferon-gamma [4S.B3] at $313.50; Brilliant Violet 650 anti-mouse CD11c [N418] at $219.00; PE/Cyanine7 anti-mouse CD45 [30-F11] at $133.00; and PerCP anti-mouse Ly-6G [1A8] at $210.00. Each line item represents a single unit purchase. These reagents are utilized in flow cytometry and other immunological research methodologies for identifying and analyzing specific cell populations in both human and murine samples.